Skip to Content

News Releases

News Releases

Date Title and Summary
Toggle Summary Chronimed Selected To Provide Transplant Medication Management Program For Prudential Healthcare Members
MINNEAPOLIS, June 16, 1999 -- Chronimed Inc. (Nasdaq: CHMD) announced today that Prudential HealthCare has selected the Chronimed Life Management Program SM to manage the medication regimens of its approximately 4,000 current transplant members and all future members who receive transplants.
Toggle Summary Chronimed Renews HIV Disease Management Contract With Blue Shield Of California
Contract Renewal Extends Relationship To Fourth Year MINNEAPOLIS, May 6, 1999 -- Chronimed Inc. (Nasdaq: CHMD), announced today that its wholly-owned subsidiary, Clinical Partners, signed a contract extension to perform HIV disease management with Blue Shield of California; the contract extends the
Toggle Summary Chronimed Renews HIV Disease Management Contract With Blue Shield Of California
Contract Renewal Extends Relationship To Fourth Year MINNEAPOLIS, May 6, 1999 -- Chronimed Inc. (Nasdaq: CHMD), announced today that its wholly-owned subsidiary, Clinical Partners, signed a contract extension to perform HIV disease management with Blue Shield of California; the contract extends the
Toggle Summary Chronimed Announces Third Quarter Fiscal 1999 Results
Also Announces Engagement of Paine Webber to Explore Strategic Alternatives MINNEAPOLIS, April 27, 1999 -- Chronimed Inc. (Nasdaq: CHMD), today announced third quarter revenue and net income for the period ended April 2, 1999. Chronimed reported record revenue for the third quarter ended April 2,
Toggle Summary Chronimed Installs Hiv Disease Management System
Only Disease Management System Of Its Kind Is Installed In Nine Cities MINNEAPOLIS, April 15, 1999 -- Chronimed Inc. (Nasdaq: CHMD), a leader in HIV/AIDS disease management, announced today that it has installed its proprietary Disease Early Warning System (DEWS) at 11 of its StatScript pharmacies
Toggle Summary Chronimed Lowers Second Half Earnings Outlook
Management Cites Short Term Timing And Performance Issues MINNEAPOLIS, March 25, 1999—Chronimed Inc. (Nasdaq: CHMD) today announced that earnings for the second half of its fiscal year 1999, ending July 2, 1999, will be significantly below analyst expectations.
Toggle Summary Chronimed Acknowledges FDA Warning Letter
Corrective Steps Were Taken Immediately; Involved No Stoppage Of Product Shipments MINNEAPOLIS, March 24, 1999 -- Chronimed Inc. (Nasdaq: CHMD), acknowledged today that it received a warning letter from the Food & Drug Administration (FDA) regarding its Eden Prairie, MN production facility.
Toggle Summary Chronimed Inc. Year 2000 Readiness Disclosure
Chronimed Inc. and its subsidiary companies Statscript Pharmacy, Clinical Partners, Inc., and Home Service Medical (collectively, the “Company”) have undertaken a Year 2000 readiness program to address the various issues surrounding Year 2000 date processing.
Toggle Summary Chronimed Files Action Against Bayer Corporation
MINNEAPOLIS, March 8, 1999 -- Chronimed Inc. (Nasdaq: CHMD), a leading manufacturer and distributor of diagnostic products since 1985, announced today that it has commenced an action against Bayer Corporation in Minneapolis federal court. The declaratory judgment action seeks a ruling that
Toggle Summary Chronimed Inc. Promotes Gregory Keane To VP Finance
MINNEAPOLIS, March 3, 1999 -- Chronimed Inc. (Nasdaq: CHMD), announced today that Gregory H. Keane has been promoted to vice president, finance from corporate controller. Prior to joining Chronimed three years ago, Keane was employed by National Computer Systems where he served as controller, and